The use of cyclodextrins nanoparticles for oral delivery

Current Medicinal Chemistry

Volumn 18, Issue 14, 2011, Pages 2079-2085

  Kanwar, J R ^a   Long, B M ^a   Kanwar, R K ^a  

^a DEAKIN UNIVERSITY   (Australia)

Author keywords

Cyclodextrins and nanoparticles; Nanodelivery; Oral administration

Indexed keywords

ACRYLIC ACID; CHITOSAN; CYCLODEXTRIN; FELBINAC; INSULIN; NANOPARTICLE; PACLITAXEL; PEPTIDE; POLYACRYLIC ACID; POLYETHER; POLYGLACTIN; POLYISOBUTYLCYANOACRYLATE; PROTEIN; ROTAXANE; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CELL MEMBRANE PERMEABILITY; CLINICAL PRACTICE; COLITIS; COMPARATIVE STUDY; DIABETES MELLITUS; DRUG ABSORPTION; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG SAFETY; DRUG STRUCTURE; DRUG TARGETING; ENZYME DEGRADATION; GASTROINTESTINAL TRACT; HUMAN; HYDROPHOBICITY; INJECTION; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROTEIN SECRETION; PROTEIN STABILITY;

EID: 79957948653     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711795656243     Document Type: Article

References (35)

1. Kanwar, J.R.; Mahidhara, G.; Kanwar, R.K. Anti-angiogenic therapy using nanotechnological based delivery system. Drug Discov. Today, 2011, 16(5-6):188-202.
2. Kanwar, J.R.; Mohan, R.R.; Kanwar, R.K.; Roy, K.; Bawa, R. Applications of aptamers in nanodelivery systems in cancer, eye and inflammatory diseases. Nanomedicine, 2010, 5(9), 1435-1445.
3. Liam, M.; Kanwar, R.K.; Zhou, S.; Punj, V.; Kanwar, J.R. Applications on nanomedicine in antibacterial medical therapeutics and diagnostics. Open Trop. Med. J., 2010, 3(1), 1-9.
4. Mohanty, C.; Das, M.; Kanwar, J.R.; Sahoo, S.K. Receptor mediated tumor targeting: an emerging approach for cancer therapy. Curr. Drug Deliv., 2011, 8(1), 45-58.
5. Tetsumi, I.; Uekamab, K. Cyclodextrins in peptide and protein delivery. Adv. Drug Deliv. Rev., 1999, 36, 101-123.
6. Sajeesh, S.; Sharma, C.P. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. Int. J. Pharm., 2006, 325, 147-154. (Pubitemid 44573692)
7. Soares, A.F.; Carvalho, R.A.; Veiga, F. Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems. Nanomedicine, 2007, 2(2), 183-202. (Pubitemid 46845766)
8. Singha, R.; Lilliard, J.W. Nanoparticle-based targeted drug delivery. Exp. Mol. Pathol., 2009, 86(3), 215-223.
9. Shaikha, J.; Ankolab, D.D.; Beniwala, V.; Singha, D.; Kumar, M.N.V.R. Nanoparticle encapsulation improves oral bioavailability of curcumin by least 9-fols when compared to curcumin administered with piperine as absorption enhancer. Eur. J. Pharm. Sci., 2009, 37(3), 223-230.
10. Zhanga, X.; Wub, Z.; Gaoa, X.; Shua, S.; Zhanga, H.; Wanga, Z.; Lia, C. Chitosan bearing pendant cyclodextrin as a carrier for controlled protein release. Carbohydrate Polymers, 2009, 77(2), 394-401.
11. Szejtli, J. Cyclodextrin Technology. Kluwer academic publishers: Budapest, Hungary, 1988.
12. Chaise, T.; Cardineal, P.; Tisse, S.; Combret, J.C.; Bouillon, J.P. Indirect and direct approaches in the synthesis of a new mono-6-O-benzyl methylated ccyclodextrin as chiral selector for enantioselective gas chromatography. Tetrahedron Asymmetry, 2008, 19(3), 348-357.
13. Bala, S.M. Invivo assessment of safety of microneedle arrays in human skin. Eur. J. Pharm. Sci., 2008, 35(3), 192-202.
14. Minami, K.; Hirayama, F.; Uekama, K. Colon specific drug delivery based on a cyclodextrin prodrug: release behavoir of biphenylacetic acid from its cyclodextrin conjugates in rat intestinal tracts after oral administration. J. Pharm. Sci., 1997, 87(6), 715-720. (Pubitemid 28268570)
15. Iriea, T.; Uekamab, K. Cyclodextrins in peptide and protein delivery. Adv. Drug Deliv. Rev., 1999, 32, 101-123.
16. Sluzky, V.; Tamada, J.A.; Klibanaov, A.M.; Langer, R. Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. Proc. Natl. Acad. Sci. USA, 1991, 88, 9377-9381. (Pubitemid 21915634)
17. Moon, C.; Kwon, Y.M.; Lee, W.K.; Park, Y.J.; Yang, V.C. In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide. J. Control. Release, 2007, 124(1-2), 43-50. (Pubitemid 350103732)
18. Bodmeier, R.; Chen, H.; Paeratakul, A. Novel approach to the oral delivery of micro- or nanoparticles. Pharm. Res., 1989, 6(5), 413-417. (Pubitemid 19176086)
19. Kawashima, Y.; Yamamoto, H.; Takeuchi, H.; Kuno, Y. Mucoadhesive dl- Lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin. Pharm. Dev. Technol., 1999, 5(1), 77-85. (Pubitemid 30069202)
20. Foger, F.; Schmitz, T.; Bernkop-Schnurch, A. In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan. Biomaterials, 2006, 27, 4250-4255.
21. Mi, F.L.; Wu, Y.Y.; Lin, Y.H.; Sonaje, K.; Ho, Y.C.; Chen, C.T.; Juang, J.H.; Sung, H.W. Oral delivery of peptide drugs using nanoparticles selfassembled by poly(α-glutamic acid) and a chitosan derivative functionalized by trimethylation. Bioconjug. Chem., 2008, 19, 1248-1255. (Pubitemid 351874948)
22. Hunt, G.R.A.; Jones, I.C. application of 1H-N.M.R. to the design of liposomes for oral use. Synergestic activity of bile salts and pancreatic phospholipase A2 in the induced permeability of small unilamellar phospholipid vesicles. J. Microencapsul., 1984, 1(2), 113-122.
23. Cuia, F. Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: Preparation, in vitro characterization and in vivo evaluation. J. Control. Release, 2006, 114(2), 242-250.
24. Garcia-Fuentes, M.; Torres, D.; Alonso, M.J. Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules. Colloids Surf. B. Biointerfaces, 2003, 27(2-3), 159-168. (Pubitemid 36042758)
25. Dong, Y.; Feng, S.S. Poly (d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials, 2005, 26(30), 6068-6076. (Pubitemid 40805612)
26. Krauland, A.H.; Alonso, M.J. Chitosan/cyclodextrin nanoparticles as macromolecular drug delivery system. Int. J. Pharm., 2007, 340(1-2), 134-142. (Pubitemid 47043346)
27. Davaran, S.; Omidi, Y.; Rashidi, M.R.; Anzabi, M.; Shayanfar, A.; Ghyasvand, S.; Vesal, N.; Davaran, F. Preparation and in vitro Evaluation of Linear and Starbranched PLGA Nanoparticles for Insulin Delivery. J Bioact Compat. Polym., 2008, 23, 115-131. (Pubitemid 351178646)
28. Xiong, X.Y.; Li, Y.P.; Li, Z.L.; Zhou, C.L.; Tam, K.C.; Liu, Z.Y.; Xie, G.X. Vesicles from Pluronic/poly(lactic acid) block copolymers as new carriers for oral insulin delivery. J. Control. Release, 2007, 120 (1-2), 11-17. (Pubitemid 46874621)
29. Trapani, A.; Lopedota, A.; Franco, M.; Cioffi, N.; Leva, E.; Garcia-Fuentes, M.; Alonso, M.J. A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides. Eur J. Pharm. Biopharm., 2010, 75(1), 26-32.
30. Babu, V.R.; Patel, P.; Mundargi. Developments in polymeric devices for oral insulin delivery. Expert Opin. Drug Deliv., 2008, 5(4), 403-415. (Pubitemid 351721720)
31. Soares, A.F.; Carvalho, R.A.; Veiga, F. Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems. Nanomedicine, 2007, 2(2), 183-202. (Pubitemid 46845766)
32. Ansari, K.A.; Torne, S.J.; Vavia, P.R.; Trotta, F.; Cavalli, R. Paclitaxel Loaded Nanosponges: In-vitro Characterization and Cytotoxicity Study on MCF-7 Cell Line Culture. Curr. Drug Deliv., 2011.
33. Torne, S.J.; Ansari, K.A.; Vavia, P.R.; Trotta, F.; Cavalli, R. Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded nanosponges. Drug Deliv., 2010, 17(6), 419-425.
34. Halim Mohamed, M.A.; Mahmoud, A.A. Formulation of Indomethacin Eye Drops via Complexation with Cyclodextrins. Curr. Eye Res., 2011
35. Gillet, A.; Lecomte, F.; Hubert, P.; Ducat, E.; Evrard, B.; Piel, G. Skin penetration behaviour of liposomes as a function of their composition. Eur. J. Pharm. Biopharm., 2011.